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ABSTRACT: This work explores the antiplasmodial potential of ethanol extract of Blighia sapida (Lin. Sapindaceae) in chloroquine (CQ)resistant Plasmodium berghei (ANKA strain)–infected mice. Chloroquine-resistant (ANKA) strain of P berghei was inoculated intraperitoneally
into Swiss albino mice. Mice were treated orally for 4 consecutive days, before and after inoculation (prophylactic, suppressive, and curative
models) with graded doses of the plant extracts with Artemether-Lumefantrine (Coartem) as control. Prophylactically, the extract showed
a remarkable activity in the chemosuppression of P berghei parasites (P < .01) ranging from 57% to 36.5% at doses of 200 to 800 mg/kg,
respectively, whereas Coartem (10 mg/kg) produced 62.1% chemosuppression. No significant chemosuppression was observed in the curative
and suppressive models. The plant extract appeared to be safe at the highest dose tested (5000 mg/kg) for acute toxicity, with no adverse effect
on the different organs. The plant extract possesses prophylactic antimalarial activity, which supports its use in the prevention of malaria.
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Introduction

Based on the latest World Health Organization (WHO) estimates of December 2016, there were 212 million cases of
malaria in 2015 and 429 000 deaths, with sub-Saharan Africa
accounting for 90% of all malaria deaths in the world.1 This
staggering number of deaths resulting from malaria is associated with the continuous spread of Plasmodium falciparum
resistance to available antimalarial drugs, posing severe threats
to existing malaria control programs. The lack of a deployable
malaria vaccine coupled with increasing cases of drug-resistant
infections makes the search for new antimalarials imperative.2,3
Owing to the high cost of malaria treatment in developing
countries in general and Nigeria in particular, many have
resulted to consulting traditional herbalists or the use of medicinal plants for treatment of infection.4
For thousands of years, in various parts of the world, traditional herbal medicines have been used to treat malaria.5–9 Two
of the most important antimalarial drugs in use, artemisinin
and quinine, were either derived directly from plants or synthesized using chemical structures of plant-derived compounds as
templates.5,9,10 Most of the people in malaria endemic countries still depend on traditional herbal remedies, which could
be linked to limited availability as well as unaffordability of
existing pharmaceutical drugs.11
Blighia sapida, also referred to as ackee or ackee apple, is a
medicinal plant of the family Sapindaceae that naturally exists
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in the forests of most West African countries, where the fruits
are used for several purposes, but rarely eaten.12 When mixed
with water, the green fruits of this plant produce lather and are
used for laundry, in addition to its seeds being used for making
soap due to its high oil content.13 Some parts of this plant also
serve medicinal purposes, such as the juice from the leaf is traditionally used to treat conjunctivitis,12 whereas its twiggy
leaves, once beaten into a pulp, are applied to the forehead for
treating migraine or headaches.14 For over 20 years, the Centre
for Scientific Research into Plant Medicine (CSRPM) in
Ghana has used this plant for the treatment of diarrhea.15 The
antidiarrheal activity of the stem bark of B sapida has also been
reported,16 including reports on its traditional use for the treatment of dysentery, yellow fever, burns, wounds, or conjunctivitis, etc.14 Murine experiments have also demonstrated its utility
in treating pancreatic β-cell dysfunction,17 elevated blood glucose, dyslipidemia, and oxidative stress in alloxan-induced diabetic rats.18
In view of the significant challenges imposed by drug resistance, traditional plant extracts continue to be promising sources
of new antimalarial compounds.9 The use of traditional medicines for the treatment of malaria and other diseases continues to
be a growing practice among many African families, despite the
availability of orthodox method of treatment.19 In addition, the
short supply of artemisinin compounds leading to alternative
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production methods,9 as well as the desire for low-cost drug
delivery strategies,7 has led to significant research efforts to decipher alternative plant products that could serve as effective antimalarials, especially in sub-Saharan Africa. In this report, the
antiplasmodial effect of ethanolic extract of B sapida stem bark in
vivo is reported, using the suppressive, curative, and prophylactic
model.

Materials and Methods
Plant collection, authentication, and extract
preparation

body weight of B sapida ethanolic extract, respectively, and
observed for 24 hours for mortality. In phase 2, 3 mice in each
group groups were orally administered with 1600, 2900, and
5000 mg/kg body weight of the extract, respectively, and monitored for 24 hours, observing for mortality. The phase 2 study
was conducted because we observed no deaths among animals
in phase 1 study. The lethal dose and the penultimate dose to
the lethal dose would indicate the value of the LD50.21,22

In vivo antiplasmodial determination

The stem bark of B sapida was collected in December 2014
from Ipetumodu in the South West of Nigeria. Plant material
was identified in the herbarium of the Botany Department of
Obafemi Awolowo University, Ile-Ife, Osun State Nigeria with
voucher number IFE-17629 by Mr GA Ademoriyo. The stem
bark was air-dried at room temperature and powdered. About
50 g of the powdered plant was macerated in 500 mL of 99%
methanol (1:10 W/V) for 48 hours and then filtered. With the
aid of a rotatory evaporator, filtrate was concentrated to dryness and the residue obtained was stored until future use.

Swiss albino mice (weight: 18-25 g), obtained from the
Animal House, Department of Pharmacology, University of
Ibadan, kept according to Institutional Animal Care and Use
Committee (IACUC) standards, were allowed to acclimatize
to the new environment for a week before study initiation.
Each mouse was inoculated with 0.2 mL of infected blood
containing about 1 × 107 dose of P berghei berghei (about
16.6%) from a donor mouse. Each mouse was inoculated on
day 0 (D0) (intraperitoneally) for the suppressive and curative model and on the fifth day (D4) for the prophylactic
model.

Ethical consideration

Suppressive test (4-day test)

Experimental procedures and protocols used in this study were
in conformity with National Institute of Health’s recommendations in guide for the care and use of laboratory animals and
in accordance with the principles of Helsinki Declaration.

Parasite/infection
Chloroquine-resistant P berghei ANKA, obtained from
Institute for Medical Research and Training (IMRAT),
University College Hospital, Ibadan, Nigeria, was used to evaluate the antimalarial activity of B sapida in this study. Groups
of Swiss albino mice (5 per cage) were infected intraperitoneally with 1 × 107 parasitized erythrocytes from an infected
donor mouse. The day of infection was defined as day 0 (D0)
and subsequent days D1, D2, etc.

Antimalarial medication
Standard Coartem (Artemether and Lumefantrine), used for
treating malaria (Mekophar Chemical Pharmaceutical JointStock Co, Ho Chi Minh City, Vietnam) and obtained from a
pharmacy, was used as reference for the antimalarial screening
in this study.

Acute toxicity test (assessment of minimum lethal
dose)
The assessment of minimum lethal dose was done in 2 phases,
following published methods.20 In phase 1, groups of 3 mice in
each group were given oral doses of 10, 100, and 1000 mg/kg

The 4-day suppressive test was conducted according to the
method of Peters (1975). In this, 25 mice distributed into 5
groups of 5 mice each were infected with 1 × 107 of parasitized
red blood cells on day 0. Animals in group 1 received normal
saline, those in groups 2 to 4 received 200, 400, and 800 mg/kg
of ethanol extract of B sapida test extract, whereas those in
group 5 (positive control) received 10 mg/kg of the standard
drug Coartem. Treatment was administered orally and continued daily for the next 3 days for the group that received
Coartem or 4 consecutive days for extract-treated group. On
day 4, blood samples were collected from the caudal vein and
stained with 10% Giemsa stain. Thereafter, the number of the
parasitized cells was estimated under the microscope using
×100 objective.23 The numbers of infected erythrocytes were
counted until 1000 erythrocytes were achieved. The average
percentage suppression of parasitemia was calculated in comparison with controls as follows:
% parasitemia in negative control _
% Suppression =

% parasitemia in test group

% parasitemia in negative control

× 100

Prophylactic test
The prophylactic activity of the extract was performed as
described previously.24 In this, Swiss albino mice were randomized into 5 groups of 5 mice each: group 1 was treated with
normal saline only, groups 2 to 4 were treated with 200, 400,
and 800 mg/kg/d of the ethanol extract of B sapida, and group
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5 served as positive control (treated with 10 mg/kg/d of the
standard drug Coartem). Treatment started on day 0 and continued for 4 consecutive days, by which mice were inoculated
intraperitoneally with 1 × 107 of the parasite. On day 7
(72 hours after inoculation), blood smears made from each
mouse were stained with Giemsa, number of the parasitized
cells was estimated, and the percentage suppression was
evaluated.

Curative test
This was also performed with standard protocol,24 as previously described. Twenty-five mice distributed into 5 groups of
5 were infected intraperitoneally on the first day (day 0) with
0.2 mL of parasite inoculum. After 72 hours of infection, all
animals were treated with different regimens: group 1 received
normal saline only; groups 2 to 4 received 200, 400, and 800 mg/
kg body weight of plant extract, respectively; whereas group 5
received 10 mg/kg body weight of the standard antimalarial
drug (Coartem). Treatment was continued for 5 consecutive
days, blood smears were made and microscopically examined to
monitor the degree of parasitemia as well as estimating the
number of parasitized cells.

Histologic procedures
These were performed with hematoxylin and eosin procedures.25
Briefly, organs such as liver, spleen, kidney, and testes from each
animal were fixed in 10% formal saline, grossed and cut longitudinally into pieces of 4 mm in thickness, and processed for histologic study using standard procedure. Microtome sections were
dried on a hot plate and later stained with hematoxylin and eosin
stains for examination with a light microscope.

Data analysis
Percentage parasitemia and mean chemosuppression were
determined using 1-way analysis of variance; StudentNewman-Keuls test was used for analysis and comparing of
results at 95% confidence interval; P < .05 was set for statistical
significance.

Results

About 11.10 g of brown crude extract was obtained from the
extraction procedure, a percentage yield of 22%. The acute toxicity test revealed that the extract appeared to be nontoxic at
the highest dose (5000 mg/kg) tested. No toxic symptoms or
mortality was observed in any of the 3 animals in 3 groups both
in phase 1 and phase 2 acute toxicity test study. All animals
were still alive at the end of the acute toxicity test, with LD50
value greater than 5000 mg/kg body weight, showing the
extract to be nontoxic. Histology sections of the liver, spleen,
kidney, and testes reveal normal tissue morphology at all doses,
except at 5000 mg/kg (black ring), where we observed a mild

Figure 1. Photomicrographs of liver and kidney at the end of acute
toxicity assessment. (A) Normal liver morphology. (B) (Black ring) mild
perivascular infiltration of the liver inflammatory cells after treatment with
5000 mg/kg of the extract. (C) Normal kidney morphology. (D) Kidney
remains normal after treatment with 5000 mg/kg of the extract.
Haematoxylin and Eosin, 400x original magnification.

perivascular infiltration of liver inflammatory cells (Figure 1);
otherwise, hepatocytes appeared normal.

Suppressive effect of B sapida ethanolic extract on P
berghei
In the suppressive test, mean parasitemia on day 4 after infection ranged from 14.20 ± 1.17 to 18.96 ± 0.60 for 200 and
800 mg/kg, respectively (Figure 2). The value for control was
19.02 ± 1.20, whereas for Coartem was 8.38 ± 0.39. The percentage chemosuppression of the extract ranged from 6.8% to 0.3%
for 200 and 800 mg/kg, respectively, whereas that for standard
antimalarial Coartem was 55.9%. Percentage chemosuppression
showed increases with decrease in dose levels of the extract,
indicating that maximal chemosuppression could be reached at
the lowest dose, although intangible. Percentage chemosuppression in Coartem was very much higher than in control and all
the doses of the extract, revealing that extract had little or no
suppressive effect at all doses. Percentage parasitemia in control,
compared with 400 and 800 mg/kg, was not statistically significant (P > .05), whereas that of 200 mg/kg compared with control, 400 and 800 mg/kg, was statistically significant (P < .01)
(Figure 2). Percentage parasitemia in Coartem was much lower
than in extract at the highest dose, showing statistical significance (P < .001), but percentage parasitemia of the lowest dose
of the extract was slightly higher in comparison with Coartem,
with the difference not significant (Figure 2).

Prophylactic effect of B sapida ethanolic extract on
P berghei
The percentage parasitemia in mice infected and treated with
200, 400, and 800 mg/kg was 8.22 ± 0.32, 9.7 ± 0.31, and
12.12 ± 0.54, respectively (Figure 3). Untreated saline group had
percentage parasitemia of 19.10 ± 0.33, whereas that of
Coartem-treated positive control was 7.24 ± 0.91. Percentage
chemosuppression of parasites in mice treated with 200, 400,
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Figure 2. Suppressive effect of methanol extract of bark of Blighia sapida on Plasmodium berghei. Bars are expressed as mean ± SEM (n = 5); ***P < .001,
Coartem versus normal saline (NS); **P < .01, 200 mg/kg versus normal saline.

Figure 3. Prophylactic effect of ethanol extract of Blighia sapida on Plasmodium berghei in mice. Bars are expressed as mean ± SEM (n = 5); ***P < .001,
test and control versus normal saline (NS).

and 800 mg/kg was 57%, 50.8%, and 36.5%, respectively,
whereas that of Coartem was 62.1%. Unlike our observation in

the suppressive model, percentage parasitemia decreased with a
decrease in extract dose levels, showing that a tangible optimal

Otegbade et al

5

Figure 4. Curative effect of ethanol extract of Blighia sapida on Plasmodium berghei in mice. NS indicates normal saline.

Table 1. Weights of mice for prophylactic model.
Dose,
mg/kg

Day 0

Day 1

Day 2

Day 3

Day 4

Day 5

Day 6

Day 7

NS

21.40 ± 1.02

21.85 ± 0.99

22.08 ± 1.0

21.94 ± 0.96

22.28 ± 1.10

21.90 ± 0.93

19.45 ± 0.83

17.02 ± 0.75

200

20.78 ± 0.92

20.16 ± 0.94

21.02 ± 1.02

20.24 ± 1.10

20.96 ± 1.03

21.40 ± 1.20

20.16 ± 1.00

21.70 ± 1.08

400

17.28 ± 0.44

17.20 ± 0.39

17.46 ± 0.54

17.36 ± 0.51

17.62 ± 0.41

18.00 ± 0.47

17.32 ± 0.43

16.96 ± 0.40

800

22.28 ± 1.21

22.20 ± 1.40

22.50 ± 1.47

21.64 ± 1.33

22.12 ± 1.34

22.80 ± 1.52

21.90 ± 1.36

22.68 ± 1.44

Coartem

19.58 ± 1.00

19.88 ± 0.90

20.14 ± 0.78

19.78 ± 0.70

19.58 ± 0.70

20.12 ± 0.75

19.52 ± 0.63

20.42 ± 0.51

Abbreviation: NS, normal saline.
The baseline weights were taken before inoculation and subsequent weights taken before, during and after treatments. Data are expressed as
mean ± SEM. Values do not indicate statistical significance to one another.

chemosuppression can be obtained at the lowest dose in this
model and is statistically significant at all doses when compared
with nontreated group (P < .001; Figure 3). The percentage of
the extract at the lowest dose (200 mg/kg) was comparable with
that of Coartem, although Coartem exhibited a highly significant (P < .001) decrease in percentage parasitemia compared
with negative control and 800 mg/kg.

Curative effect of B sapida ethanolic extract on P
berghei
Figure 4 shows curative effect of the extract at different graded
doses. Unlike the suppressive and prophylactic models, none of
the extract doses tested showed significant activity. The lowest
dose (200 mg/kg) that had shown significant activity in other
models showed no activity in our model. For day 3, the values
for Coartem versus control versus 200 mg/kg of the extract was
1.74 ± 0.29 versus 7.58 ± 0.44 versus 7.18 ± 0.82, with similar
findings on day 7 (21.48 ± 0.68, 17.00 ± 0.58, and 2.06 ± 0.39 for
control), 200 mg/kg of extract and Coartem, respectively,

revealing the extract had no significant activity against the
parasite when compared with control.

Effect of malaria on weight of malaria-induced
mice
The weights of all test animals decreased 24 hours after infection, with this decrease continuing among the suppressive,
curative, and untreated groups 72 hours after treatment.
However, by day 5 (21.40 ± 1.20), this progressive weight loss
was turned around for the prophylactic group when compared
with the weights obtained at the same dose on day 0
(20.78 ± 0.92) and day 7 (21.70 ± 1.08) (Table 1).

Effect of B sapida ethanolic extract on organs of P
berghei–infected mice
The kidney, liver, and spleen of the mice revealed normal tissue
architecture after treatment, demonstrating that this extract
appears safe on the major organs of the mice (slides not shown).
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Figure 5. Graph showing survival time of mice in the 3 models.

Survival time of mice in the 3 models
The survival time for mice in the prophylactic group was longer
than those in suppressive and curative groups (Figure 5). Mice
in prophylactic group started dying on day 9, whereas most
were still alive at day 20 and beyond. However, animals in curative group started dying on day 5 and were all dead by day 9,
whereas those in the suppressive group started dying on day 5
with 98% dead by day 11. These results clearly demonstrate the
prophylactic effect of this extract, at different doses, on malariainfected animal.

Discussion

Despite the many and varying efforts at malaria control, this
disease is still a global threat of enormous proportion and a
significant contributor to health and economic inequities in
endemic countries. Inhabitants of these countries, under the
scourge of disease, face the conundrum of finding appropriate,
effective, and cheap means to protect themselves against infection, whereas the parasite, however, has shown an increasing
resistance to available antimalarial drugs. This resistance is also
favored by population movement and human migration leading to the introduction of resistant parasite to areas previously
free of drug resistance. The possibility of synthesizing new
antimalarials from plants has become a major policy goal in the
control arena, becoming more urgent, in light of the limited
number of antimalarials in development, the potential of parasite resistance to the only available therapeutic drugs (artemisinin and its derivatives), and the poor solubility of
artemisinin. These are some of the factors driving the design of
alternative methods of artemisinin delivery that could potentially slow the process of resistance evolution.10,26,27 We demonstrate that B sapida investigated in this study possesses
antimalarial properties that deserve further analysis and could
become a cheap, readily available antimalarial in developing
countries.
This study shows that B sapida has remarkable activity
(almost equivalent with Coartem), when used as a prophylactic agent in chloroquine-resistant P berghei–infected mice,

Drug Target Insights 
with the 7-day assay leading to a significant parasitemia suppression. Maximum activity was recorded at the lowest dose
(200 mg/kg), with a decrease with increasing dosage, implying
that the extract had no pronounced activity at higher doses,
and that the small dose suffices to produce significant antimalarial activity. This observation concurs with previous result,
where the minimum inhibitory activity shown by the methanolic extract of B sapida against Staphylococcus aureus started at
a dose of 200 mg/mL, but further increase in activity was seen
as the dose was decreased to 100 mg/mL, suggesting that the
lower the dose, the higher the activity displayed.28 It is worth
noting that B sapida extract exhibited the most active antiplasmodial properties at the lowest dosage tested. This dosedependent activity potentially shows that response at low dose
is more effective than response inhibition at high dose.29 Our
results show that B sapida extracts will serve as excellent antimalarial agent in the prophylactic model of treatment.
The absence of death after administering 5000 mg/kg body
weight of B sapida extract in the acute toxicity test suggests that
the extract appears to be nontoxic, an observation supported by
the toxicity scale principle, which states that any chemical
showing an LD50 greater than 5000 mg/kg is practically nontoxic.30 In this report, the acute toxicity test conducted with the
extracts demonstrate their safety because the highest dose
caused no death. Interestingly, the highest dose used to treat
parasite-infected mice from which antimalarial activity was
elicited was much lower than the highest acute dose, thus making the extract quite selective and safe.
Loss of appetite, ultimately leading to weight loss, is one of
the characteristics of malaria infection.31 We observed weight
loss in P berghei–infected animals after infection, with the initial weight loss recorded reversed after 5 days of treatment with
the extracts in the prophylactic group, but not in the curative
and suppressive groups, which showed progressive weight loss.
This result in the suppressive and curative groups agrees with
earlier report of continuous weight loss among treated animals
compared with nontreated animals32 but disagrees with our
previous study using extracts from Russelia equisetiformis, which
showed a reversal in body weight after treatment.3 However,
the prophylactic group in this study where we observed slight
increase after treatment agrees with our previous study.
The survival time for mice in the prophylactic group
extended beyond day 20, whereas those in the curative model
did not survive beyond day 9. About 98% of the mice in the
suppressive model were dead by day 15, with only 2% surviving
till day 20 but not beyond, further confirming the prophylactic
activity of B sapida ethanol extract.
Although there have been some reports of B sapida poisoning in people who consumed the fruit (ackee) in particular,33–37
such poisonous effect was not observed with the stem bark
used in our study. Histologic examination of the liver, kidney,
and spleen showed no toxicity to the organs after treatment
with the at all doses used, agreeing with the results

Otegbade et al
of a different study using Blighia unijugata, which showed no
toxicity to the liver and kidney when administered in a dosedependent fashion to Wistar rats more than 4 weeks.38
Histology of the testes reveals that extract has no toxic effect
on male animals and as such not inhibitory to fertility. The difference in the reported toxicity may be due to the part of the
plant examined. The seed is toxic, whereas the stem bark
appears safe.
Conclusively, our results suggest that the ethanol bark
extract of B sapida show some intrinsic antimalarial activities
by its prophylactic ability against chloroquine-resistant P
berghei parasites. This performance can surely be improved on
in future studies if the crude extract is purified and the active
substituents are identified and the doses further fractionated.
The extracts have considerably low toxicities in experimental
mice, this result supporting the traditional use of this plant for
the prophylactic treatment of malaria only.
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